TissueNexus

You queried the gene APP in brain:

Symbol	Synonyms	map_location	description
APP	AAA\|ABETA\|ABPP\|AD1\|APPI\|CTFgamma\|CVAP\|PN-II\|PN2\|preA4	21q21.3	amyloid beta precursor protein

Local network

The network contains the top 25 neighbors, and 178 gene pairs are found in total.

Download gene network data

Weight:

Network analysis
Gene analysis

Local Network
Gene Ontology Enrichment
Disease/traits enrichment

The weight between APP and the top connected 25 genes.

Gene A	Gene B	Weight

Gene Ontology Enrichment Analysis (Biological Process Terms)

Enrichment Results for APP and its neighbors in brain network

GO ID	GO name	FDR

GO:0070997	neuron death	3.18e-25
GO:0007626	locomotory behavior	4.63e-25
GO:1901214	regulation of neuron death	8.00e-24
GO:0008344	adult locomotory behavior	1.27e-23
GO:0048638	regulation of developmental growth	3.21e-22
GO:0030534	adult behavior	9.99e-20
GO:0046677	response to antibiotic	1.49e-19
GO:1901215	negative regulation of neuron death	4.97e-19
GO:0006979	response to oxidative stress	4.02e-18
GO:0035264	multicellular organism growth	4.07e-18
GO:1901652	response to peptide	7.51e-18
GO:0040014	regulation of multicellular organism growth	1.47e-17
GO:0051402	neuron apoptotic process	1.32e-16
GO:0042063	gliogenesis	2.44e-16
GO:0061564	axon development	7.96e-16
GO:0043523	regulation of neuron apoptotic process	2.82e-15
GO:0048872	homeostasis of number of cells	4.33e-15
GO:0007409	axonogenesis	2.62e-14
GO:0006816	calcium ion transport	2.69e-14
GO:0007568	aging	3.33e-14
GO:1901653	cellular response to peptide	4.19e-14
GO:0010038	response to metal ion	7.56e-14
GO:0034599	cellular response to oxidative stress	7.58e-14
GO:0071900	regulation of protein serine/threonine kinase activity	8.20e-14
GO:0030099	myeloid cell differentiation	1.63e-13
GO:0050890	cognition	1.71e-13
GO:0007611	learning or memory	1.81e-13
GO:0070588	calcium ion transmembrane transport	1.90e-13
GO:0034248	regulation of cellular amide metabolic process	2.39e-13
GO:0000302	response to reactive oxygen species	3.73e-13
GO:0042110	T cell activation	4.48e-13
GO:0002521	leukocyte differentiation	5.15e-13
GO:0032496	response to lipopolysaccharide	6.18e-13
GO:0070838	divalent metal ion transport	6.62e-13
GO:0010001	glial cell differentiation	6.72e-13
GO:0072511	divalent inorganic cation transport	8.84e-13
GO:2001233	regulation of apoptotic signaling pathway	1.10e-12
GO:0043524	negative regulation of neuron apoptotic process	1.21e-12
GO:0006874	cellular calcium ion homeostasis	1.22e-12
GO:0070371	ERK1 and ERK2 cascade	1.42e-12
GO:0090066	regulation of anatomical structure size	2.37e-12
GO:0035690	cellular response to drug	2.78e-12
GO:0002237	response to molecule of bacterial origin	3.20e-12
GO:0055074	calcium ion homeostasis	4.22e-12
GO:0097193	intrinsic apoptotic signaling pathway	4.77e-12
GO:0042391	regulation of membrane potential	7.71e-12
GO:0051235	maintenance of location	9.24e-12
GO:0051403	stress-activated MAPK cascade	1.08e-11
GO:0034249	negative regulation of cellular amide metabolic process	1.50e-11
GO:0048511	rhythmic process	1.57e-11

No enrichment is identified for this network.

Tissue-specific analysis
Gene Ontology
Human phenotype ontology
GWAS
Drug

Tissue-specific expression distribution of APP.

Gene ontology annotations for the queried gene based on Gene Ontology.

BP: Biological Process, MF: Molecular Function, CC: Cellular Component.

Gene	GO_ID	GO_term	Category	Evidence
APP	GO:0000978	RNA polymerase II cis-regulatory region sequence-specific DNA binding	MF	IEA
APP	GO:0001774	microglial cell activation	BP	IGI
APP	GO:0001934	positive regulation of protein phosphorylation	BP	IDA,IGI
APP	GO:0001967	suckling behavior	BP	IEA
APP	GO:0002265	astrocyte activation involved in immune response	BP	IGI
APP	GO:0002576	platelet degranulation	BP	TAS
APP	GO:0003677	DNA binding	MF	ISS
APP	GO:0004867	serine-type endopeptidase inhibitor activity	MF	IDA
APP	GO:0005102	signaling receptor binding	MF	IPI
APP	GO:0005515	protein binding	MF	IPI
APP	GO:0005576	extracellular region	CC	TAS
APP	GO:0005615	extracellular space	CC	HDA,IDA
APP	GO:0005641	nuclear envelope lumen	CC	IDA
APP	GO:0005737	cytoplasm	CC	IDA,ISS
APP	GO:0005768	endosome	CC	IDA
APP	GO:0005769	early endosome	CC	ISS
APP	GO:0005788	endoplasmic reticulum lumen	CC	TAS
APP	GO:0005790	smooth endoplasmic reticulum	CC	IEA
APP	GO:0005791	rough endoplasmic reticulum	CC	IEA
APP	GO:0005794	Golgi apparatus	CC	IDA,ISS
APP	GO:0005796	Golgi lumen	CC	TAS
APP	GO:0005798	Golgi-associated vesicle	CC	ISS
APP	GO:0005829	cytosol	CC	TAS
APP	GO:0005886	plasma membrane	CC	IDA,TAS
APP	GO:0005887	integral component of plasma membrane	CC	TAS
APP	GO:0005905	clathrin-coated pit	CC	IEA
APP	GO:0005911	cell-cell junction	CC	IEA
APP	GO:0006378	mRNA polyadenylation	BP	ISS
APP	GO:0006417	regulation of translation	BP	ISS
APP	GO:0006468	protein phosphorylation	BP	ISS
APP	GO:0006878	cellular copper ion homeostasis	BP	ISS
APP	GO:0006897	endocytosis	BP	ISS
APP	GO:0006979	response to oxidative stress	BP	IEA
APP	GO:0007155	cell adhesion	BP	IEA
APP	GO:0007176	regulation of epidermal growth factor-activated receptor activity	BP	ISS
APP	GO:0007186	G protein-coupled receptor signaling pathway	BP	TAS
APP	GO:0007219	Notch signaling pathway	BP	IEA
APP	GO:0007409	axonogenesis	BP	ISS
APP	GO:0007611	learning or memory	BP	IGI,IMP,TAS
APP	GO:0007612	learning	BP	IMP
APP	GO:0007617	mating behavior	BP	ISS
APP	GO:0007626	locomotory behavior	BP	ISS
APP	GO:0008021	synaptic vesicle	CC	IEA
APP	GO:0008088	axo-dendritic transport	BP	ISS
APP	GO:0008201	heparin binding	MF	IEA
APP	GO:0008203	cholesterol metabolic process	BP	IEA
APP	GO:0008285	negative regulation of cell population proliferation	BP	IDA
APP	GO:0008344	adult locomotory behavior	BP	ISS
APP	GO:0008542	visual learning	BP	ISS
APP	GO:0009986	cell surface	CC	IDA
APP	GO:0009987	cellular process	BP	IMP
APP	GO:0010288	response to lead ion	BP	IEA
APP	GO:0010468	regulation of gene expression	BP	IGI,IMP
APP	GO:0010628	positive regulation of gene expression	BP	IGI,IMP
APP	GO:0010629	negative regulation of gene expression	BP	IGI
APP	GO:0010800	positive regulation of peptidyl-threonine phosphorylation	BP	IMP
APP	GO:0010951	negative regulation of endopeptidase activity	BP	IEA
APP	GO:0010952	positive regulation of peptidase activity	BP	IEA
APP	GO:0010971	positive regulation of G2/M transition of mitotic cell cycle	BP	IEA
APP	GO:0014005	microglia development	BP	IGI
APP	GO:0016021	integral component of membrane	CC	ISS
APP	GO:0016199	axon midline choice point recognition	BP	ISS
APP	GO:0016322	neuron remodeling	BP	ISS
APP	GO:0016358	dendrite development	BP	ISS
APP	GO:0016504	peptidase activator activity	MF	IEA
APP	GO:0019899	enzyme binding	MF	IPI
APP	GO:0030111	regulation of Wnt signaling pathway	BP	IC
APP	GO:0030134	COPII-coated ER to Golgi transport vesicle	CC	IEA
APP	GO:0030198	extracellular matrix organization	BP	ISS,TAS
APP	GO:0030424	axon	CC	ISS
APP	GO:0030546	signaling receptor activator activity	MF	IEA
APP	GO:0030900	forebrain development	BP	IEA
APP	GO:0031093	platelet alpha granule lumen	CC	TAS
APP	GO:0031175	neuron projection development	BP	ISS
APP	GO:0031594	neuromuscular junction	CC	IEA
APP	GO:0031904	endosome lumen	CC	TAS
APP	GO:0032092	positive regulation of protein binding	BP	IGI
APP	GO:0032588	trans-Golgi network membrane	CC	TAS
APP	GO:0032722	positive regulation of chemokine production	BP	IGI
APP	GO:0032731	positive regulation of interleukin-1 beta production	BP	IGI
APP	GO:0032755	positive regulation of interleukin-6 production	BP	IGI
APP	GO:0032760	positive regulation of tumor necrosis factor production	BP	IGI
APP	GO:0033138	positive regulation of peptidyl-serine phosphorylation	BP	IMP
APP	GO:0035235	ionotropic glutamate receptor signaling pathway	BP	ISS
APP	GO:0035253	ciliary rootlet	CC	IEA
APP	GO:0040014	regulation of multicellular organism growth	BP	ISS
APP	GO:0042327	positive regulation of phosphorylation	BP	IGI
APP	GO:0042802	identical protein binding	MF	IPI
APP	GO:0043197	dendritic spine	CC	IDA
APP	GO:0043198	dendritic shaft	CC	IDA
APP	GO:0043204	perikaryon	CC	IEA
APP	GO:0043235	receptor complex	CC	IDA
APP	GO:0043687	post-translational protein modification	BP	TAS
APP	GO:0044267	cellular protein metabolic process	BP	TAS
APP	GO:0044304	main axon	CC	IEA
APP	GO:0045087	innate immune response	BP	TAS
APP	GO:0045121	membrane raft	CC	IDA
APP	GO:0045177	apical part of cell	CC	IEA
APP	GO:0045202	synapse	CC	IDA
APP	GO:0045665	negative regulation of neuron differentiation	BP	IEA
APP	GO:0045821	positive regulation of glycolytic process	BP	IGI
APP	GO:0045931	positive regulation of mitotic cell cycle	BP	ISS
APP	GO:0045944	positive regulation of transcription by RNA polymerase II	BP	IGI
APP	GO:0046330	positive regulation of JNK cascade	BP	IGI
APP	GO:0046914	transition metal ion binding	MF	IEA
APP	GO:0048143	astrocyte activation	BP	IGI
APP	GO:0048169	regulation of long-term neuronal synaptic plasticity	BP	IGI
APP	GO:0048471	perinuclear region of cytoplasm	CC	IDA
APP	GO:0048669	collateral sprouting in absence of injury	BP	ISS
APP	GO:0048786	presynaptic active zone	CC	IEA
APP	GO:0050729	positive regulation of inflammatory response	BP	IMP
APP	GO:0050730	regulation of peptidyl-tyrosine phosphorylation	BP	IGI
APP	GO:0050803	regulation of synapse structure or activity	BP	ISS
APP	GO:0050808	synapse organization	BP	IGI
APP	GO:0050885	neuromuscular process controlling balance	BP	IEA
APP	GO:0050890	cognition	BP	ISS
APP	GO:0051091	positive regulation of DNA-binding transcription factor activity	BP	IGI
APP	GO:0051092	positive regulation of NF-kappaB transcription factor activity	BP	IGI
APP	GO:0051124	synaptic growth at neuromuscular junction	BP	IEA
APP	GO:0051233	spindle midzone	CC	IEA
APP	GO:0051247	positive regulation of protein metabolic process	BP	IMP,ISS
APP	GO:0051402	neuron apoptotic process	BP	IMP
APP	GO:0051425	PTB domain binding	MF	IPI
APP	GO:0051563	smooth endoplasmic reticulum calcium ion homeostasis	BP	IEA
APP	GO:0055037	recycling endosome	CC	ISS
APP	GO:0070062	extracellular exosome	CC	HDA
APP	GO:0070374	positive regulation of ERK1 and ERK2 cascade	BP	IGI
APP	GO:0070555	response to interleukin-1	BP	ISS
APP	GO:0070851	growth factor receptor binding	MF	IEA
APP	GO:0071280	cellular response to copper ion	BP	IEA
APP	GO:0071287	cellular response to manganese ion	BP	IEA
APP	GO:0071320	cellular response to cAMP	BP	IEA
APP	GO:0071874	cellular response to norepinephrine stimulus	BP	IEA
APP	GO:0090647	modulation of age-related behavioral decline	BP	IGI,IMP,TAS
APP	GO:0097449	astrocyte projection	CC	IEA
APP	GO:0098815	modulation of excitatory postsynaptic potential	BP	IGI
APP	GO:0150003	regulation of spontaneous synaptic transmission	BP	IGI
APP	GO:1900272	negative regulation of long-term synaptic potentiation	BP	IGI
APP	GO:1900273	positive regulation of long-term synaptic potentiation	BP	IGI
APP	GO:1901224	positive regulation of NIK/NF-kappaB signaling	BP	IGI,IMP
APP	GO:1904646	cellular response to amyloid-beta	BP	IGI
APP	GO:1905598	negative regulation of low-density lipoprotein receptor activity	BP	IGI
APP	GO:1905606	regulation of presynapse assembly	BP	IDA,IMP
APP	GO:1905908	positive regulation of amyloid fibril formation	BP	IMP
APP	GO:1990000	amyloid fibril formation	BP	IMP
APP	GO:1990090	cellular response to nerve growth factor stimulus	BP	IEA
APP	GO:1990535	neuron projection maintenance	BP	IGI
APP	GO:1990761	growth cone lamellipodium	CC	IEA
APP	GO:1990812	growth cone filopodium	CC	IEA
APP	GO:2000310	regulation of NMDA receptor activity	BP	TAS
APP	GO:2000406	positive regulation of T cell migration	BP	IMP

Associated human phenotype annotations for the queried gene based on Human Phenotype Ontology(2019).

Gene	HPO-ID	HPO-Name	Disease
APP	HP:0000708	Behavioral abnormality	Cerebral amyloid angiopathy, APP-related
APP	HP:0011970	Cerebral amyloid angiopathy	Cerebral amyloid angiopathy, APP-related
APP	HP:0002315	Headache	Cerebral amyloid angiopathy, APP-related
APP	HP:0000726	Dementia	Cerebral amyloid angiopathy, APP-related
APP	HP:0001342	Cerebral hemorrhage	Cerebral amyloid angiopathy, APP-related
APP	HP:0001250	Seizure	Cerebral amyloid angiopathy, APP-related
APP	HP:0100613	Death in early adulthood	Cerebral amyloid angiopathy, APP-related
APP	HP:0002514	Cerebral calcification	Cerebral amyloid angiopathy, APP-related
APP	HP:0001297	Stroke	Cerebral amyloid angiopathy, APP-related
APP	HP:0000708	Behavioral abnormality	Cerebral amyloid angiopathy, APP-related
APP	HP:0002373	Febrile seizure (within the age range of 3 months to 6 years)	Cerebral amyloid angiopathy, APP-related
APP	HP:0002511	Alzheimer disease	Alzheimer disease
APP	HP:0000726	Dementia	Alzheimer disease
APP	HP:0000006	Autosomal dominant inheritance	Alzheimer disease
APP	HP:0001425	Heterogeneous	Alzheimer disease
APP	HP:0001300	Parkinsonism	Alzheimer disease
APP	HP:0002185	Neurofibrillary tangles	Alzheimer disease
APP	HP:0410054	Decreased level of GABA in serum	Alzheimer disease
APP	HP:0002423	Long-tract signs	Alzheimer disease
APP	HP:0002076	Migraine	Cerebral amyloid angiopathy, APP-related
APP	HP:0001250	Seizure	Cerebral amyloid angiopathy, APP-related
APP	HP:0001342	Cerebral hemorrhage	Cerebral amyloid angiopathy, APP-related
APP	HP:0001297	Stroke	Cerebral amyloid angiopathy, APP-related
APP	HP:0000726	Dementia	Cerebral amyloid angiopathy, APP-related
APP	HP:0001259	Coma	Cerebral amyloid angiopathy, APP-related
APP	HP:0002354	Memory impairment	Alzheimer disease, type 14
APP	HP:0001249	Intellectual disability	Alzheimer disease, type 14
APP	HP:0001300	Parkinsonism	Alzheimer disease, type 14
APP	HP:0002120	Cerebral cortical atrophy	Alzheimer disease, type 14
APP	HP:0030219	Semantic dementia	Alzheimer disease, type 14
APP	HP:0002463	Language impairment	Alzheimer disease, type 14
APP	HP:0010526	Dysgraphia	Alzheimer disease, type 14
APP	HP:0001276	Hypertonia	Alzheimer disease, type 14
APP	HP:0001289	Confusion	Alzheimer disease, type 14
APP	HP:0012433	Abnormal social behavior	Alzheimer disease, type 14
APP	HP:0001250	Seizure	Alzheimer disease, type 14
APP	HP:0002381	Aphasia	Alzheimer disease, type 14
APP	HP:0000713	Agitation	Alzheimer disease, type 14
APP	HP:0002185	Neurofibrillary tangles	Alzheimer disease, type 14
APP	HP:0000504	Abnormality of vision	Alzheimer disease, type 14
APP	HP:0003791	Deposits immunoreactive to beta-amyloid protein	Alzheimer disease, type 14
APP	HP:0010525	Finger agnosia	Alzheimer disease, type 14
APP	HP:0000657	Oculomotor apraxia	Alzheimer disease, type 14
APP	HP:0000734	Disinhibition	Alzheimer disease, type 14
APP	HP:0001336	Myoclonus	Alzheimer disease, type 14
APP	HP:0000738	Hallucinations	Alzheimer disease, type 14
APP	HP:0001251	Ataxia	Alzheimer disease, type 14
APP	HP:0000726	Dementia	Cerebral amyloid angiopathy, APP-related
APP	HP:0002076	Migraine	Cerebral amyloid angiopathy, APP-related
APP	HP:0001259	Coma	Cerebral amyloid angiopathy, APP-related
APP	HP:0003401	Paresthesia	Cerebral amyloid angiopathy, APP-related
APP	HP:0001249	Intellectual disability	Cerebral amyloid angiopathy, APP-related
APP	HP:0001342	Cerebral hemorrhage	Cerebral amyloid angiopathy, APP-related
APP	HP:0000708	Behavioral abnormality	Cerebral amyloid angiopathy, APP-related
APP	HP:0001297	Stroke	Cerebral amyloid angiopathy, APP-related
APP	HP:0001263	Global developmental delay	Cerebral amyloid angiopathy, APP-related
APP	HP:0004938	Tortuous cerebral arteries	Cerebral amyloid angiopathy, APP-related
APP	HP:0001297	Stroke	Cerebral amyloid angiopathy, APP-related
APP	HP:0000006	Autosomal dominant inheritance	Cerebral amyloid angiopathy, APP-related
APP	HP:0011695	Cerebellar hemorrhage	Cerebral amyloid angiopathy, APP-related
APP	HP:0004968	Recurrent cerebral hemorrhage	Cerebral amyloid angiopathy, APP-related
APP	HP:0000726	Dementia	Cerebral amyloid angiopathy, APP-related
APP	HP:0002637	Cerebral ischemia	Cerebral amyloid angiopathy, APP-related
APP	HP:0011970	Cerebral amyloid angiopathy	Cerebral amyloid angiopathy, APP-related
APP	HP:0000726	Dementia	Cerebral amyloid angiopathy, APP-related
APP	HP:0001342	Cerebral hemorrhage	Cerebral amyloid angiopathy, APP-related
APP	HP:0001288	Gait disturbance	Cerebral amyloid angiopathy, APP-related
APP	HP:0002354	Memory impairment	Cerebral amyloid angiopathy, APP-related
APP	HP:0000708	Behavioral abnormality	Cerebral amyloid angiopathy, APP-related
APP	HP:0001297	Stroke	Cerebral amyloid angiopathy, APP-related
APP	HP:0001336	Myoclonus	Cerebral amyloid angiopathy, APP-related
APP	HP:0002015	Dysphagia	Cerebral amyloid angiopathy, APP-related

Your queried gene is not associated with any traits/disease in GWAS Catalog.

Associated drugs for the queried gene based on DGIdb (2021-May).

'-': indicating missing value not available in DGIdb.

Gene	DrugName	Score	Type	Source
APP	BAN2401	4.16	-	TTD
APP	Ponezumab	4.16	-	TTD
APP	CHEMBL1743058	4.16	-	ChemblInteractions
APP	GSK933776	4.16	-	TTD
APP	CHEMBL2109300	4.16	-	ChemblInteractions
APP	CHEMBL2108576	4.16	-	ChemblInteractions
APP	CHEMBL1743072	4.16	-	ChemblInteractions
APP	CHEMBL1743004	4.16	-	ChemblInteractions
APP	CHEMBL3833321	4.16	inhibitor	ChemblInteractions
APP	CHEMBL1743025	4.16	-	ChemblInteractions
APP	MABT5102A	4.16	-	TdgClinicalTrial
APP	SOLANEZUMAB	4.16	-	TdgClinicalTrial
APP	Solanezumab	4.16	-	TTD
APP	Gantenerumab	4.16	-	TTD
APP	BAN2401	4.16	-	TdgClinicalTrial
APP	BAPINEUZUMAB	4.16	-	TdgClinicalTrial
APP	GANTENERUMAB	4.16	-	TdgClinicalTrial
APP	Crenezumab	4.16	-	TTD
APP	PONEZUMAB	4.16	-	TdgClinicalTrial
APP	Bapineuzumab	4.16	-	TTD
APP	REL-3,4-DICAFFEOYLQUINIC ACID	2.77	-	DTC
APP	DB05088	2.77	-	DrugBank
APP	REL-3,5-DICAFFEOYLQUINIC ACID	2.77	-	DTC
APP	FERULIC ACID	2.77	-	DTC
APP	NSC-649410	2.77	-	DTC
APP	2-(4-NITROPHENYL)BENZO[D]THIAZOLE	2.77	-	DTC
APP	CHEMBL3039540	1.39	-	ChemblInteractions
APP	ACC-001	1.39	-	TdgClinicalTrial
APP	Tramiprosate	1.39	-	TTD
APP	DB03754	1.39	inhibitor	DrugBank
APP	CAPROSPINOL	1.39	-	TdgClinicalTrial
APP	SCYLLO-INOSITOL	0.92	-	TdgClinicalTrial
APP	ELND005	0.92	-	TTD
APP	DB14517	0.69	-	DrugBank
APP	DB14518	0.69	-	DrugBank
APP	T-817MA	0.69	-	TTD
APP	DB04892	0.46	-	DrugBank
APP	DB06782	0.46	-	DrugBank
APP	POSIPHEN	0.46	-	TdgClinicalTrial
APP	NIC5-15	0.46	-	TTD
APP	PF-03084014	0.28	-	TTD
APP	HYDROXYCHLOROQUINE	0.23	-	NCI
APP	2-CHLORO-ADENOSINETRIPHOSPHATE	0.23	-	DTC
APP	DB00746	0.18	-	DrugBank
APP	CLIOQUINOL	0.15	-	DTC
APP	PARAROSANILINE	0.13	-	DTC
APP	PROPOFOL	0.1	-	NCI
APP	CONGO RED	0.09	-	DTC
APP	GENTIAN VIOLET	0.08	-	DTC
APP	DB02709	0.08	-	DrugBank
APP	RESVERATROL	0.08	-	DTC
APP	Curcumin	0.07	-	TTD
APP	CURCUMIN	0.07	-	DTC
APP	DB09130	0.04	inhibitor	DrugBank
APP	DAUNOMYCIN	0.04	-	NCI
APP	DB14533	0.03	ligand	DrugBank
APP	DB01593	0.02	cofactor	DrugBank
APP	DB09149	-	binder	DrugBank
APP	ALZ-801	-	-	TTD
APP	Affitope AD-01	-	-	TTD
APP	AAB-003/PF-05236812	-	-	TTD
APP	MER-5101	-	-	TTD
APP	AAB-002	-	-	TTD
APP	Systebryl	-	-	TTD
APP	DB14548	-	ligand	DrugBank
APP	DWP-09031	-	-	TTD
APP	ALZT-OP1	-	-	TTD
APP	FRM-0962	-	-	TTD
APP	ACI-24	-	-	TTD
APP	CSP-1103	-	-	TTD
APP	GSK933776A	-	-	TTD
APP	Anti-N3pG-Abeta antibody	-	-	TTD
APP	DB05938	-	-	DrugBank
APP	BAF	-	-	NCI
APP	Myo-inositol	-	-	TTD
APP	11C-AZD-2184	-	-	TTD
APP	DB09151	-	binder	DrugBank
APP	TAXANES	-	-	NCI
APP	DB14487	-	-	DrugBank
APP	SAR228810	-	-	TTD
APP	EB-101	-	-	TTD
APP	UB-311	-	-	TTD
APP	11C-6-Me-BTA-1	-	-	TTD
APP	V-950	-	-	TTD
APP	Pepticlere	-	-	TTD
APP	DB02235	-	-	DrugBank
APP	DB05846	-	-	DrugBank
APP	AD-03	-	-	TTD
APP	NRM8499	-	-	TdgClinicalTrial
APP	DB09148	-	binder	DrugBank
APP	AD01	-	-	TdgClinicalTrial
APP	AMB	-	-	NCI
APP	DB01370	-	-	DrugBank
APP	DB05150	-	-	DrugBank
APP	HOMOTAURINE	-	-	TdgClinicalTrial
APP	EXEBRYL-1	-	-	TdgClinicalTrial
APP	BIIB037	-	-	TTD
APP	NI-101	-	-	TTD
APP	CAD-106	-	-	TTD
APP	AN-1792	-	-	TTD
APP	Florbetapir F-18	-	-	TTD
APP	NN-818	-	-	TTD
APP	BIIB037	-	-	TdgClinicalTrial